Intelligent Medicine Acquisition Corp.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a IQMD research report →
Price Chart
About the company
Intelligent Medicine Acquisition Corp. currently has no active business operations. Instead, its primary objective is to seek and finalize a merger, stock exchange, asset acquisition, or other form of business combination with one or more existing companies.
- CEO
- Gregory C. Simon
- IPO
- 2021
- HQ
- Bethesda, MD, US
Get TickerSpark's AI analysis on IQMD
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $0
- P/E
- 22.53
- PEG
- 0.00
- P/S
- 0.00
- P/B
- 1.27
- EV/EBITDA
- 0.00
- Div Yield
- 0.00%
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- 5.80%
- ROIC
- 0.00%
Latest fiscal year · YoY change
- Revenue
- $0+0.0%
- Gross Profit
- $0+0.0%
- Op Income
- $0
- Net Income
- $11.41M+0.0%
- EPS
- $0.49+0.0%
- OCF Growth
- +100.0%
- FCF Growth
- +100.0%
- 52W High
- $11.22
- 52W Low
- $10.75
- 50D MA
- $0.00
- 200D MA
- $0.00
- Beta
- 0.00
- RSI (14)
- 83
- Avg Volume
- 0
No earnings-call transcripts are available for IQMD yet.
of shares held by institutions
62 13F filers
Buy/sell ratio 0.00. Sells can include pre-scheduled 10b5-1 plan sales, not just discretionary selling.
Top institutional holders
Largest 13F positions, with quarter-over-quarter change.
| Holder | Shares | Δ Quarter |
|---|---|---|
| Spring Creek Capital LLC | 250.00K | ▲ 250.00K |
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Apr 17, 23 | GOLDMAN SACHS GROUP INC | other | 0 |
| Apr 17, 23 | GOLDMAN SACHS GROUP INC | other | 1,067 |
| Feb 24, 23 | Saba Capital Management, L.P. | sell | 2,170,581 |
| Feb 8, 23 | Intelligent Medicine Sponsor LLC | other | 200,000 |
| May 5, 22 | Saba Capital Management, L.P. | other | 0 |
| Oct 13, 22 | Saba Capital Management, L.P. | other | 999,888 |
| May 5, 22 | Saba Capital Management, L.P. | other | 0 |
| Nov 4, 21 | Schocken Joseph L | other | 25,000 |
| Nov 4, 21 | Intelligent Medicine Sponsor LLC | other | 4,900,000 |
| Nov 4, 21 | Simon Gregory C | other | 4,900,000 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our IQMD coverage
Recent articles, reports, and earnings notes.
No research on IQMD yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate IQMD report →Intelligent Medicine Acquisition Corp. Announces It Will Redeem Its Public Shares
businesswire.com · Apr 26
Intelligent Medicine Acquisition Corp. Announces Adjournment of Special Meeting of Stockholders
businesswire.com · Feb 3
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.